Carlyle Trims Nature's Bounty Assets: Private Equity Rolls In Supplement Space

Carlyle's $2.2bn sale of Nature's Bounty's Holland & Barrett business to a Russian investment fund is the latest sign of the private equity sector's continuing interest in the health and wellness space.